Search results for "Immunologic"

showing 10 items of 1115 documents

Inflammation Causes Resistance to Anti-CD20–Mediated B Cell Depletion

2016

B cells play a central role in antibody-mediated rejection and certain autoimmune diseases. However, B cell-targeted therapy such as anti-CD20 B cell-depleting antibody (aCD20) has yielded mixed results in improving outcomes. In this study, we investigated whether an accelerated B cell reconstitution leading to aCD20 depletion resistance could account for these discrepancies. Using a transplantation model, we found that antigen-independent inflammation, likely through toll-like receptor (TLR) signaling, was sufficient to mitigate B cell depletion. Secondary lymphoid organs had a quicker recovery of B cells when compared to peripheral blood. Inflammation altered the pharmacokinetics (PK) and…

Graft RejectionMalemedicine.drug_classInflammation030230 surgeryMonoclonal antibodyArticleLymphocyte DepletionMice03 medical and health sciences0302 clinical medicinemedicineAnimalsImmunologic FactorsImmunology and AllergyPharmacology (medical)ReceptorB cellInflammationB-LymphocytesMice Inbred BALB CTransplantationbiologybusiness.industryGraft SurvivalAlloimmunityImmunoglobulins IntravenousAntigens CD20Mice Inbred C57BLTransplantationmedicine.anatomical_structureImmunologybiology.proteinHeart TransplantationFemaleRituximabAntibodymedicine.symptomRituximabbusiness030215 immunologymedicine.drugAmerican Journal of Transplantation
researchProduct

Insect immunity: oral exposure to a bacterial pathogen elicits free radical response and protects from a recurring infection

2014

Background: Previous exposure to a pathogen can help organisms cope with recurring infection. This is widely recognised in vertebrates, but increasing occasions are also being reported in invertebrates where this phenomenon is referred to as immune priming. However, the mechanisms that allow acquired pathogen resistance in insects remain largely unknown. Results: We studied the priming of bacterial resi stance in the larvae of the tiger moth, Parasemia plantaginis using two gram-negative bacteria, a pathogenic Serratia marcescens and a non-pathogenic control, Escherichia coli. Asublethaloraldoseof S. marcescens provided the larvae with effective protection against an otherwise lethal septic…

Gram-negative bacteriaimmune primingDefence mechanismsBacterial resistanceMicrobiology03 medical and health sciencesImmune systemAntibiotic resistanceImmunityParasemia plantaginisimmunological loiteringPathogenSerratia marcescensEcology Evolution Behavior and Systematics030304 developmental biologyinsect immunityreactive oxygen species0303 health sciencesbiology030306 microbiologyResearchImmunological loiteringfungibacterial resistancebiology.organism_classificationGram-negativegram-negativeInsect immunitySerratia marcescensImmunologyparasemia plantaginisParasemia plantaginisAnimal Science and ZoologyImmune primingReactive oxygen speciesFrontiers in Zoology
researchProduct

The gut microbiota - a modulator of endothelial cell function and a contributing environmental factor to arterial thrombosis.

2019

Introduction: There is emerging evidence linking the commensal gut microbiota with the development of cardiovascular disease and arterial thrombosis. In immunothrombosis, the host clotting system protects against the dissemination of invading microbes, not considering the huge number of microbes that interact with host physiology in a mutualistic fashion. Areas covered: Interestingly, recent research revealed that colonizing gut microbes profoundly influence host innate immune pathways that support arterial thrombus growth. The gut microbiota promotes arterial thrombus formation by enhancing the pro-adhesive capacity of the vascular endothelium, triggering hepatic von Willebrand factor synt…

Gut floraEnvironment03 medical and health sciences0302 clinical medicineVon Willebrand factorCell AdhesionMedicineAnimalsHumansPlateletPlatelet activationImmunologic SurveillanceToll-like receptorInnate immune systembiologybusiness.industryEndothelial CellsThrombosisHematologyArteriesmedicine.diseasebiology.organism_classificationThrombosisGastrointestinal MicrobiomeEndothelial stem cell030220 oncology & carcinogenesisImmunologybiology.proteinDisease SusceptibilityEndothelium VascularbusinessBiomarkers030215 immunologyExpert review of hematology
researchProduct

Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient dat…

2002

Background and aims: Retreatment with a combination of α interferon (IFN) plus ribavirin of patients with chronic hepatitis C who did not respond to IFN monotherapy has not been assessed in large controlled studies. Methods: To assess the effectiveness and tolerability of IFN/ribavirin retreatment of non-responders to IFN and to identify predictors of complete (biochemical and virological) sustained response, we performed a meta-analysis of individual data on 581 patients from 10 centres. Retreatment with various IFN schedules (mean total dose 544 mega units) and a fixed ribavirin dose (1000–1200 mg/daily depending on body weight) was given for 24–60 (mean 39.5) weeks. Results: Biochemical …

HCV interferon ribavirinAdultMalemedicine.medical_specialtyCombination therapymedicine.medical_treatmentAlpha interferonGastroenterologyAntiviral AgentsDrug Administration Schedulechemistry.chemical_compoundDrug TherapyInternal medicineRibavirinmedicineHumansImmunologic FactorsTreatment FailureChronicAdverse effectChemotherapyAdult; Antiviral Agents; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy; Combination; Female; Hepatitis C; Chronic; Humans; Immunologic Factors; Interferon-alpha; Logistic Models; Male; Middle Aged; Ribavirin; Treatment Failure; gamma-GlutamyltransferaseChi-Square Distributionbusiness.industryRibavirinLiver DiseaseGastroenterologyInterferon-alphaHepatitis Cgamma-GlutamyltransferaseHepatitis C ChronicMiddle Agedmedicine.diseaseHepatitis CConfidence intervalhumanitiesSurgeryLogistic ModelschemistryTolerabilityCombinationDrug Therapy CombinationFemalebusiness
researchProduct

Assessment of the Optimum Linker Tethering Site of Alternariol Haptens for Antibody Generation and Immunoassay Development

2021

Immunochemical methods for mycotoxin analysis require antigens with well-defined structures and antibodies with outstanding binding properties. Immunoreagents for the mycotoxins alternariol and/or alternariol monomethyl ether have typically been obtained with chemically uncharacterized haptens, and antigen conjugates have most likely been prepared with mixtures of functionalized molecules. For the first time, total synthesis was performed, in the present study, to obtain two haptens with opposite linker attachment locations. The functionalized synthetic haptens were purified and deeply characterized by different spectrometric methods, allowing the preparation of bioconjugates with unequivoc…

Hapten designImmunoassayLinker siteMolecular StructureHealth Toxicology and MutagenesisRImmunologic TestsMycotoxinsToxicologyArticlealternariolAlternariolLactonesalternariol; antibody; ELISA; hapten design; immunoassay; linker siteantibodyAntibody FormationMedicineELISABinding Sites Antibodyimmunoassaylinker siteHaptensAntibodyhapten design
researchProduct

A lytic mechanism based on soluble phospholypases A2 (sPLA2) and b-galactoside specific lectins is exerted by Ciona intestinalis (ascidian) unilocula…

2011

Abstract Hemocytes from the ascidian Ciona intestinalis exert in vitro Ca 2+ -dependent cytotoxic activity toward mammalian erythrocytes and K562 cells. To examine the lytic mechanism, hemocyte populations were separated (B1–B6 bands) through a Percoll discontinuous density gradient, the hemocyte cytotoxic activity (HCA) and the lytic activity of the hemocyte lysate supernatant (HLS) were assayed. In addition the separated hemocytes were cultured and the cell-free culture medium (CFM) assayed after 3 h culture. Results support that unilocular refractile hemocytes (URGs), enriched in B5, are cytotoxic. The B5-HLS contains lysins and the activity of B5-CFM shows that lysins can be released in…

HemocytesPhospholipase A2 Inhibitorsmedicine.medical_treatmentLysinDibucaineSettore BIO/05 - ZoologiaAquatic ScienceBiologyFucoseCell membranechemistry.chemical_compoundmedicineEnvironmental ChemistryAnimalsHumansCiona intestinalisLectins C-TypeEnzyme InhibitorsProteaseErythrocyte MembraneGeneral Medicinebiology.organism_classificationCytotoxicity Tests Immunologicbeta-GalactosidaseGalactosideCiona intestinalisPhospholipases A2medicine.anatomical_structurechemistryBiochemistryLytic cycleInvertebrate immunity Ciona intestinalis Hemocyte Cytotoxicity Soluble phospholipase A2 Rabbit erythrocyte K562QuinacrineCaspasesImmunologyMicroscopy Electron ScanningRabbitsK562 CellsPercoll
researchProduct

Gene expression specificity of the mussel antifungal mytimycin (MytM)

2011

Abstract We previously reported the nucleotide sequences and diversity of mytimycin (MytM) from the Mediterranean mussel, Mytilus galloprovincialis. Using real-time PCR (q-PCR), we observed that the MytM gene was mainly expressed in circulating hemocytes and to a less extent in the mantle. In vivo challenge with bacteria or with the yeast, Candida albicans, did not increase the expression as measured by q-PCR in hemocytes. By contrast, injection of the filamentous fungus, Fusarium oxysporum, induced a sudden and strong increase of expression at 9h p.i. (stimulation index of 25.7 ± 2.1). Optimum stimulating dose was 104 spores of F. oxysporum per mussel. In the same samples, AMP mytilin and …

Hemocytesbeta-GlucansspecificityStimulationAquatic ScienceMicrobiologyMicrococcusAntifungal peptidechemistry.chemical_compoundAdjuvants ImmunologicFusariumGene expressionEnvironmental ChemistryAnimalsCandida albicansVibrioMytilusInnate immunitybiologyQ-PCRMytilinGene Expression ProfilingGeneral MedicineMyticinbiology.organism_classificationYeastGene expression profilingchemistryGene Expression RegulationchallengeBacteriaAntimicrobial Cationic Peptides
researchProduct

Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants

2005

The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).

Hepatitis B vaccineSettore MED/42 - Igiene Generale e ApplicataImmunization Secondarymedicine.disease_causeTimeOrthohepadnavirusparasitic diseasesHumanshepatitis B vaccination long-term efficacy virus mutantsMedicineHepatitis B VaccinesHepatitis B AntibodiesHepatitis B virusGeneral VeterinaryGeneral Immunology and MicrobiologybiologyImmunization Programsbusiness.industryPublic Health Environmental and Occupational HealthHepatitis BHepatitis Bbiology.organism_classificationmedicine.diseaseVirologyVaccinationInfectious DiseasesHepadnaviridaeDNA ViralMutationMolecular MedicineViral diseasebusinessViral hepatitisImmunologic Memorygeographic locationsVaccine
researchProduct

Precision wormlike nanoadjuvant governs potency of vaccination

2021

It remains unclear how the precise length of one-dimensional nanovehicles influences the characters of vaccination. Here, a unimolecular nanovehicle with tailored size and aspect ratio (AR) is applied to deliver CpG oligodeoxynucleotide, a Toll-like receptor (TLR) 9 agonist, as an adjuvant of recombinant hepatitis B virus surface antigen (rHBsAg), for treating chronic hepatitis B (CHB). Cationic nanovehicles with fixed width (ca. 45 nm) but varied length (46 nm-180 nm), AR from 1 to 4, are prepared through controlled polymerization and are loaded with CpG by electrostatic interaction. We reveal that the nanoadjuvant with AR = 2 shows the highest retention in proximal lymph nodes. Importantl…

Hepatitis B virusCpG OligodeoxynucleotideChemistryMechanical Engineeringmedicine.medical_treatmentVaccinationTLR9BioengineeringGeneral ChemistryCondensed Matter Physicsmedicine.disease_causeMolecular biologyDisease Models AnimalMiceImmune systemCpG siteAdjuvants ImmunologicmedicineAnimalsGeneral Materials ScienceReceptorAdjuvantLate endosome
researchProduct

The asialoglycoprotein receptor as target structure in autoimmune liver diseases.

1991

Hepatologybusiness.industryLiver DiseasesT-LymphocytesComputational biologyAsialoglycoprotein ReceptorAutoimmune DiseasesHepatitisText miningImmunologyMedicineHumansAsialoglycoprotein receptorReceptors ImmunologicbusinessAutoantibodiesSeminars in liver disease
researchProduct